Magnetic nanoplatforms at the tumor redox interface: from catalytic ROS amplification to ferroptosis and multimodal cancer therapy
- 1Department of Internal Diseases No. 2, West Kazakhstan Marat Ospanov Medical University
- 2Student Research Committee, School of Dentistry, Shiraz University of Medical Sciences
- 3Department of Internal Diseases No. 1, West Kazakhstan Marat Ospanov Medical University
Abstract
Reactive oxygen species (ROS)-mediated cancer therapy has emerged as a promising strategy for inducing oxidative stress and cancer cell death. Among available nanomaterials, magnetic nanoparticles (MNPs) are particularly attractive because of their magnetic responsiveness, tunable physicochemical properties, and capacity to generate or amplify intracellular ROS within the tumor microenvironment. MNPs can disrupt cellular redox homeostasis through Fenton and Fenton-like reactions, chemodynamic therapy, ferroptosis, and mitochondrial dysfunction, thereby activating multiple cancer cell death pathways. Recent advances in nanomaterial engineering have further improved their therapeutic potential through surface functionalization, compositional optimization, targeted delivery, and stimuli-responsive design. ROS-generating magnetic nanoplatforms have also been integrated with chemotherapy, magnetic hyperthermia, photothermal therapy, photodynamic therapy, and immunotherapy to achieve synergistic antitumor effects. However, important challenges remain, including limited ROS-generation efficiency, tumor heterogeneity, biosafety concerns, and barriers to clinical translation. This review summarizes the fundamental principles and mechanisms of ROS-mediated cancer therapy using MNPs, discusses major engineering and combination-therapy strategies, and evaluates current limitations and future perspectives. Particular emphasis is placed on relationships between nanoparticle composition, structure, catalytic behavior, tumor responsiveness, and therapeutic outcomes and clinical translation strategies. These insights may support the rational design of next-generation magnetic nanoplatforms for more effective and precise cancer treatment.
Related
- GAMPoint: Geometry-augmented vision transformer with a multimodal-ready interface for 3D point-cloud segmentation
- Direct Amplification-Free Nanopore Sequencing of Leishmania from Cutaneous Biopsies
- Nuclear Genome Amplification of Antibody VDJ Regions in Wastewater
- Near point‐of‐care nucleic acid amplification tests (NPOC‐NAATs) using respiratory specimens for detection of pulmonary tuberculosis
- PLK4 inhibition-mediated centrosome amplification drives anti-tumor activity across euploid solid tumors
BibTeX
@article{kurmanalina2026magnetic,
title = {{Magnetic nanoplatforms at the tumor redox interface: from catalytic ROS amplification to ferroptosis and multimodal cancer therapy}},
author = {Gulnara Kurmanalina and Vadim Medovchshikov and Setareh Valanik and Raisa Aringazina},
journal = {Frontiers in Oncology},
year = {2026},
month = oct,
doi = {10.3389/fonc.2026.2001431},
url = {https://www.frontiersin.org/articles/10.3389/fonc.2026.2001431/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Magnetic nanoplatforms at the tumor redox interface: from catalytic ROS amplification to ferroptosis and multimodal cancer therapy
AU - Gulnara Kurmanalina
AU - Vadim Medovchshikov
AU - Setareh Valanik
AU - Raisa Aringazina
PY - 2026
DA - 2026/10/20
JO - Frontiers in Oncology
DO - 10.3389/fonc.2026.2001431
UR - https://www.frontiersin.org/articles/10.3389/fonc.2026.2001431/full
AB - Reactive oxygen species (ROS)-mediated cancer therapy has emerged as a promising strategy for inducing oxidative stress and cancer cell death. Among available nanomaterials, magnetic nanoparticles (MNPs) are particularly attractive because of their magnetic responsiveness, tunable physicochemical properties, and capacity to generate or amplify intracellular ROS within the tumor microenvironment. MNPs can disrupt cellular redox homeostasis through Fenton and Fenton-like reactions, chemodynamic therapy, ferroptosis, and mitochondrial dysfunction, thereby activating multiple cancer cell death pathways. Recent advances in nanomaterial engineering have further improved their therapeutic potential through surface functionalization, compositional optimization, targeted delivery, and stimuli-responsive design. ROS-generating magnetic nanoplatforms have also been integrated with chemotherapy, magnetic hyperthermia, photothermal therapy, photodynamic therapy, and immunotherapy to achieve synergistic antitumor effects. However, important challenges remain, including limited ROS-generation efficiency, tumor heterogeneity, biosafety concerns, and barriers to clinical translation. This review summarizes the fundamental principles and mechanisms of ROS-mediated cancer therapy using MNPs, discusses major engineering and combination-therapy strategies, and evaluates current limitations and future perspectives. Particular emphasis is placed on relationships between nanoparticle composition, structure, catalytic behavior, tumor responsiveness, and therapeutic outcomes and clinical translation strategies. These insights may support the rational design of next-generation magnetic nanoplatforms for more effective and precise cancer treatment.
SN - 2234-943X
ER -